Fennec Pharmaceuticals, Inc. (FENC)
11.71
+0.31
(+2.72%)
USD |
NASDAQ |
Aug 25, 16:00
11.74
+0.03
(+0.26%)
After-Hours: 19:59
Fennec Pharmaceuticals Profit Margin (Quarterly) : 11.04% for June 30, 2026
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 11.04% |
| March 31, 2026 | 1.33% |
| December 31, 2025 | -37.34% |
| September 30, 2025 | -5.12% |
| June 30, 2025 | -32.66% |
| March 31, 2025 | -13.31% |
| December 31, 2024 | -20.43% |
| September 30, 2024 | -82.23% |
| June 30, 2024 | -76.47% |
| March 31, 2024 | 50.59% |
| December 31, 2023 | -27.55% |
| September 30, 2023 | -28.66% |
| Date | Value |
|---|---|
| June 30, 2023 | -163.7% |
| March 31, 2023 | -360.9% |
| December 31, 2022 | -446.7% |
| September 30, 2022 | |
| June 30, 2022 | |
| March 31, 2022 | |
| December 31, 2021 | |
| September 30, 2021 | |
| June 30, 2021 | |
| March 31, 2021 | |
| December 31, 2020 | -1.90K% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Abeona Therapeutics, Inc. | -177.4% |
| ACADIA Pharmaceuticals, Inc. | 10.23% |
| Alnylam Pharmaceuticals, Inc. | 12.74% |
| Anika Therapeutics, Inc. | 10.15% |
| Savara, Inc. | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -17.41% |
| Return on Assets | -5.78% |
| Return on Invested Capital | -12.90% |
| Gross Profit Margin (Quarterly) | 95.97% |
| Operating Margin (Quarterly) | 9.72% |
| Return on Net Operating Assets | -11.83% |